BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11384992)

  • 1. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
    Buschmann T; Lerner D; Lee CG; Ronai Z
    J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
    Tago K; Chiocca S; Sherr CJ
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J; Goodson ML; Hong Y; Sarge KD
    J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
    Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
    J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanistic view of the role of E3 in sumoylation.
    Tozluoğlu M; Karaca E; Nussinov R; Haliloğlu T
    PLoS Comput Biol; 2010 Aug; 6(8):. PubMed ID: 20865051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pellino-1, an adaptor protein of interleukin-1 receptor/toll-like receptor signaling, is sumoylated by Ubc9.
    Kim JH; Sung KS; Jung SM; Lee YS; Kwon JY; Choi CY; Park SH
    Mol Cells; 2011 Jan; 31(1):85-9. PubMed ID: 21120624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.
    Stindt MH; Carter S; Vigneron AM; Ryan KM; Vousden KH
    Cell Cycle; 2011 Sep; 10(18):3176-88. PubMed ID: 21900752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation.
    Knipscheer P; van Dijk WJ; Olsen JV; Mann M; Sixma TK
    EMBO J; 2007 Jun; 26(11):2797-807. PubMed ID: 17491593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UBC9 E2 SUMO conjugating enzyme binds the PR-Set7 histone methyltransferase to facilitate target gene repression.
    Spektor TM; Congdon LM; Veerappan CS; Rice JC
    PLoS One; 2011; 6(7):e22785. PubMed ID: 21829513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification.
    Kurtzman AL; Schechter N
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5602-7. PubMed ID: 11331779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells.
    Huang CH; Yang TT; Lin KI
    J Biomed Sci; 2024 Jan; 31(1):16. PubMed ID: 38280996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca
    Silveirinha VC; Lin H; Tanifuji S; Mochida S; Cottrell GS; Cimarosti H; Stephens GJ
    Cell Calcium; 2021 Jan; 93():102326. PubMed ID: 33360835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency.
    López I; Chalatsi E; Ellenbroek SIJ; Andrieux A; Roux PF; Cerapio JP; Jouvion G; van Rheenen J; Seeler JS; Dejean A
    Oncogene; 2020 Oct; 39(43):6692-6703. PubMed ID: 32948837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights Into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9.
    Hewitt WM; Lountos GT; Zlotkowski K; Dahlhauser SD; Saunders LB; Needle D; Tropea JE; Zhan C; Wei G; Ma B; Nussinov R; Waugh DS; Schneekloth JS
    Angew Chem Int Ed Engl; 2016 May; 55(19):5703-7. PubMed ID: 27038327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-dependent SUMO modification of PARP-1.
    Zilio N; Williamson CT; Eustermann S; Shah R; West SC; Neuhaus D; Ulrich HD
    DNA Repair (Amst); 2013 Sep; 12(9):761-73. PubMed ID: 23871147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBC9 autosumoylation negatively regulates sumoylation of septins in Saccharomyces cerevisiae.
    Ho CW; Chen HT; Hwang J
    J Biol Chem; 2011 Jun; 286(24):21826-34. PubMed ID: 21518767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBC9-mediated SUMOylation of Lamin B1 enhances DNA-damage-induced nuclear DNA leakage and autophagy after spinal cord injury.
    Fan YP; Lou JS; Jin MR; Zhou CH; Shen HH; Fu CY; Mao XJ; Chen YY; Zhong JJ; Wang LL; Wu JS
    J Cell Physiol; 2024 May; 239(5):e31213. PubMed ID: 38308641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observation of an E2 (Ubc9)-homodimer by crystallography.
    Alontaga AY; Ambaye ND; Li YJ; Vega R; Chen CH; Bzymek KP; Williams JC; Hu W; Chen Y
    Data Brief; 2016 Jun; 7():195-200. PubMed ID: 27408909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal α-amino SUMOylation of cofilin-1 is critical for its regulation of actin depolymerization.
    Weng W; Gu X; Yang Y; Zhang Q; Deng Q; Zhou J; Cheng J; Zhu MX; Feng J; Huang O; Li Y
    Nat Commun; 2023 Sep; 14(1):5688. PubMed ID: 37709794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBC9 stabilizes PFKFB3 to promote aerobic glycolysis and proliferation of glioblastoma cells.
    Meng Z; Bian X; Ma L; Zhang G; Ma Q; Xu Q; Liu J; Wang R; Lun J; Lin Q; Zhao G; Jiang H; Qiu W; Fang J; Lu Z
    Int J Biochem Cell Biol; 2023 Dec; 165():106491. PubMed ID: 38149579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.